Navigation Links
China-Biotics, Inc. to Present at China's 3rd Annual Food Safety Technology Forum 2008
Date:7/8/2008

SHANGHAI, China, July 8 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced Dr. Shuguang Fang, China-Biotics' Chief Technology Officer, has been invited to be the guest speaker at China's 3rd Annual Food Safety Technology Forum 2008 (the "Forum").

The Forum, organized by Ringier Trade Publishing Ltd., will be held July 8-9, 2008, at the Renaissance Shanghai Pudong Hotel in Shanghai, China. Dr. Fang will address the topic of "Probiotics Safety in Dairy Products" on Wednesday, July 9.

"We are honored to share our expertise in the application of probiotics as bulk additives with all the related parties at the Forum," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "Both the Chinese government and the Chinese public place great importance on food safety technology, as the standard of living continues to improve in China. We anticipate that the demand for probiotics as bulk additives will increase substantially once consumers realize the benefits and trust the safety of this technology."

The Forum will present an integrated approach to the safety and management of milk and dairy products, functional beverages, beer and alcohol, convenience foods and meat, poultry and fish products. For more information, please visit http://www.industrysourcing.com/English/web/Detail.aspx?conferenceid=32 .

About Ringier Trade Publishing Ltd

Ringier Trade Publishing Ltd. is the Hong Kong-based subsidiary of Ringier AG, the Swiss multimedia communications group founded in Zurich in 1831. Ringier publishes 26 specialized industry magazines for China, in simplified Chinese, reaching more than 560,000 decision-makers in Chin
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
4. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
5. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
6. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. China-Biotics, Inc. Completes Foundation for Its New Plant
9. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
10. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ael, December 2 Gamida Cell announ...inical (animal study) safety and,efficacy of a gen...eill,Cornell Medical College and Gamida Cell. The ...ias such as Cooley,s Anemia. , Gamida Cel..., ex vivo,populations of stem/progenitor cells. T...
(Date:12/2/2009)...wswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ:...armaceutical company focused on endocrine therapy ...nd Drug Administration (FDA) has granted Fast Trac...nhibitor compound, perifosine (KRX-0401), for the ... Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX),...
(Date:12/1/2009)...olomon announced that he has joined Carolina Eyeca...ite at www.DrKerrySolomon.com , which was develop...proven LASIK, lens implant, and cataract surgery e...is substantial contributions to improving vision c...K Surgeons, which screens LASIK surgeons based upo...
(Date:12/1/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Emerging Clinical Trial Locations - E...althcare and regulatory environment ,, http:/...rial-Locations---Eastern-Europe-Market-dynamics-an...nt.html ,, Over the last decade pharmaceutical...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...sults for Sponsoring Brands , , CINCINNATI, May 1... provider of physician office-based patient-educat... in 2008. In a challenging economic climate, the ...h, posting 21% year-over-year revenue growth. The...ting room program and an exam room program), offer...
...apeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) toda...h Auction" tender offer (the "Exchange Offer") to ...("Common Stock"), and cash for an aggregate of $89...tanding series of Convertible Notes (the "Notes"):...ated Notes due 2010 , 5.75% Convertible Seni...
... - German Chemical Parks Record Growth - Attracti...f employees in German chemical parks has increased...8. In this same period, the number of,companies do...920. These,figures were presented today by Dr. Kla...oup of Chemical Parks and Sites in the German Chem...
Other Biology Technology:Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy 2Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 2Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 3Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 4Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 5Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 610,000 New Jobs, Investments Increased 210,000 New Jobs, Investments Increased 3
(Date:12/1/2009)...ner of the 2009 Inserm Grand Prix., Every year s...aying tribute to outstanding,work performed in it...ts, Inserm intends to,demonstrate the diversity a...ical, medical and,health research, and the creati...t and,drive this research each day. The Inserm 20...
(Date:12/1/2009)...t-and-run attacks by sharks can be solved with a n...nique chomp they put on their victims, according t...ert. , In a method analogous to analyzing human ...by precisely comparing shark bites to the jaws and...ess, director of the International Shark Attack Fi...
(Date:12/1/2009)...onash University-led international research team h... of the next generation of solar cells. , Scient...olleagues from the universities of Wollongong and ...d solar cells with a three-fold increase in energy...ported tandem dye-sensitised solar cells. , Lea...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Innovation puts next-generation solar cells on the horizon 2Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 1Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 2Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 3Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 4Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 5Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 6Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 7Abbott HIV Test Demonstrates Earlier Disease Detection 13141 1Abbott HIV Test Demonstrates Earlier Disease Detection 13141 2Abbott HIV Test Demonstrates Earlier Disease Detection 13141 3Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 1Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 2Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 3Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 4Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 5
...University of Florida and University of Texas at A...arwin called the abominable mystery of early plant...ext week in the Proceedings of the National Academ...largest groups of flowering plants are more closel...r lineages. These are the monocots, which include ...
...ovement research program by Dr. Dariusz Malinowski...sses as an alternative to winter wheat pastures. ,...grown in many parts of the nation, said Malinowski...gronomist in Vernon. They are from the Mediterrane... Our climate is changing here, he said. Its been ...
...lutionary scientist Niles Eldredge and his son Gre... it,s time to help science educators fight back ag...blic education. So they joined forces with the sci...ay in February this year, announced plans to publi...h. , The print version will debut at the National...
Other Biology News:UF botanists: Flowering plants evolved very quickly into 5 groups 2UF botanists: Flowering plants evolved very quickly into 5 groups 3Summer-dormant tall fescue grass shows promise for pasture improvements 2Summer-dormant tall fescue grass shows promise for pasture improvements 3An intelligent new way to support the teaching of evolution 2
Yeast Nitrogen Base from Invitrogen
Streptavidin, PE conjugated/tagged from Invitrogen
Rabbit Anti-Human PVRL2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
GIBCO AmnioMAX-C100 Basal Medium liquid from Invitrogen
Biology Products: